Healthcare & Life Sciences

Select Engagements
  • Dienen, Inc.

    Newly formed ESOP
    acquired 100% interest
    Financial Opinion

  • Follow-on equity
    to the ESOP
    Financial Advisor
    Learn more

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • Life Care Services, LLC

    ESOP
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • ASC 805
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

  • ESOP
    Valuation Client

  • ASC 805
    Valuation Client

  • IRC 409A / ASC 718
    Valuation Client

Chartwell offers financial advisory and consulting to firms in the healthcare and life sciences sector.

We have considerable experience working with companies in the healthcare and life sciences sector.  In particular, we have a long history of supporting early stage medical device firms. Areas of expertise include:

  • Healthcare Services
  • Senior Care Services
  • Home Healthcare Services
  • Life Science Tools
  • Medical Devices and Supplies
  • Branded, Specialty, and Generic Pharmaceuticals
  • Biotechnology 
  • Healthcare Software, Hardware, and IT Services
Dienen Fairness
Pima 2015 M&A
Ability - EQ
Amphora - EQ
Cardialen - EQ
Conventus Ortho - EQ
Enobia - EQ
Holaira - EQ
Inspire - EQ
LCS - ESOP
Lutonix - EQ
Minnetronix - EQ
NxThera - EQ
Phraxis - EQ
Restore Medical - EQ
SterilMed - FR
SuperDimension - EQ
Respicardia - EQ
Veran Medical - EQ
VGM - ESOP
Woodbury Products - FR
Zyga - EQ